Performance Evaluation of Early Sepsis Indicator at ASAN Medical Center Emergency Department

 

In this webinar recorded at ISLH 2020, Dr. Chan-Jeoung Park, professor in the Department of Laboratory Medicine at ASAN Medical Center, University of Ulsan College of Medicine in Seoul, Korea discusses the performance evaluation of the Early Sepsis Indicator at ASAN Medical Center Emergency Department.

Sepsis is a global problem with up to 49 million people affected by the condition worldwide.1 The early detection of sepsis in the emergency department is a pressing problem. In this webinar, Dr. Park will discuss the performance evaluation of the Early Sepsis Indicator. Dr. Park’s clinical research examines the outcomes of 549 patients presenting to the emergency department, using sepsis-3 criteria for sepsis definition.

After attending the webinar, you will be able to:

  • Learn how Monocyte Distribution Width (MDW) can be an effective and sensitive biomarker for sepsis detection in patients visiting the Emergency Department (ED)
  • Understand the performance of MDW for sepsis detection compared to other biomarkers, Procalcitonin and C-reactive Protein
  • See that the combination of MDW & WBC results can be obtained rapidly by CBC-Diff on DxH 900 and can be used as an aid in sepsis diagnosis in the ED

Presenter: Professor Chan-Jeoung Park, M.D., Ph.D.

Dr. Park is a professor in the Department of Laboratory Medicine at ASAN Medical Center, University of Ulsan College of Medicine in Seoul, Korea. She received her M.D., M.S. and Ph.D. degrees from the College of Medicine and Post-graduate schools of Medicine at Seoul National University. Dr. Park completed her internship and residency in the Department of Laboratory Medicine, Seoul National University Hospital where she studied hematology, with emphasis in pathology at Pittsburgh University Hospital in the U.S.

Her diagnostic and research expertise are in hematologic malignancies with emphasis in leukemia in hematopathology and flow cytometry and the clinical utility of automatic hematology analyzers in laboratory hematology. She has published many papers as a first or corresponding author in the several international journals and has received academic awards from the Korean Federation of Science & Technology Societies, the Korean Society for Laboratory Medicine, the Korean Society for Laboratory Hematology and the Korean Society of Hematology.

Dr. Park has served as president of the Korean Society for Laboratory Hematology and congress chairwoman of the Korean Society of Hematology. She is currently the president of the Korean Society for Laboratory Medicine.

1Rudd, et al., Lancet. 2020 Jan 18; 395 (10219): 200-211.